Oncology Central

In Focus blood cancer

0
Numerous advancements have been made in treatment options for hematologic malignancies, with a big emphasis on precision medicine. As the field moves forwards with a stronger focus on individualized care, more questions are arising about how we can better identify minimal residual disease, reduce toxicity and identify molecular targets in subsets of patients; in order to better understand which patients need more or less therapy or a different treatment regime.

In this In Focus, we explore the latest developments and emerging concepts in the field of hematologic malignancies through discussions with experts in the field, infographics which provide visual snapshots of the disease as well as informative opinion pieces and patient perspectives. You can find links to all this and more below, where we’ve collated our top hematologic oncology content from the past year keep you up-to-date in this ever-moving field.

Share:

Leave A Comment